Predictive Oncology Inc. (POAI) NASDAQ
4.91
+0.29(+6.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.91
+0.29(+6.28%)
Currency In USD
| Market Cap | 124.62M |
| Enterprise Value | 115.5M |
| P/E Ratio | -0.78 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 591.17 |
| Price/Book Ratio | 4.61 |
| Enterprise/Revenue | 481.94 |
| Enterprise/EBITDA | -0.24 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -4,740.21 |
| Operating Margin | -588.06 |
| Return On Assets | -5.27 |
| Return On Equity | -107.05 |
| Revenue | 125,284 |
| Revenue/Share | 0 |
| Gross Profit | 52,662 |
| EBITDA | -27.74M |
| Net Income | -233.1M |
| Diluted EPS | -13.37 |
| Total Cash | 6.93M |
| Total Cash/Share | 0.33 |
| Total Debt | 1.43M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 8.89 |
| Book Value Per Share | 1.9 |
| 52-Week Change | -69.97 |
| 52-Week High | 45.9 |
| 52-Week Low | 1.21 |
| Moving Average 50 Days | 8.42 |
| Moving Average 200 Days | 13.27 |
| Average Volume | 141,651 |
| Shares Outstanding | 726,080 |
| % Held by Institutions | 1.95 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | September 30, 2025 |